ArticleInternational journal of molecular sciences2020

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.

Saioa Mendaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.